Clinical Scorecard: Predicting Adverse Outcomes in Neurosurgical Patients Using Machine Learning: Exploring the Impact of Liver Function Indicators
At a Glance
Category
Detail
Condition
Neurosurgical diseases including traumatic brain injury (TBI), intracerebral hemorrhage (ICH), and aneurysmal subarachnoid hemorrhage (aSAH)
Key Mechanisms
Integration of neurological status (Glasgow Coma Scale) and liver function markers (AST, albumin, ALKP) reflecting the liver-brain axis influencing neurological prognosis
Target Population
Patients aged ≥16 years hospitalized with TBI, ICH, or aSAH without pre-existing severe liver disease
Care Setting
Neurosurgery department inpatient setting with access to liver function testing
Key Highlights
Machine learning model (CatBoost) achieved high accuracy (AUC=0.932) in predicting unfavorable functional outcomes at discharge
Key predictors included admission GCS score, age, and liver function markers (AST, albumin, ALKP)
Lower GCS, older age, higher AST and ALKP, and lower albumin levels were associated with worse prognosis
Guideline-Based Recommendations
Diagnosis
Assess neurological status using Glasgow Coma Scale at admission
Perform liver function tests including AST, albumin, and ALKP on admission for neurosurgical patients
Management
Incorporate liver function markers into prognostic assessment to identify patients at risk of unfavorable outcomes
Use machine learning models integrating neurological and hepatic parameters to guide early intervention strategies
Monitoring & Follow-up
Monitor liver function markers dynamically during hospitalization to detect worsening hepatic dysfunction
Regularly assess neurological status alongside liver function to evaluate prognosis
Risks
Recognize that hepatic dysfunction may exacerbate neurological deterioration via the liver-brain axis
Be aware that elevated AST and ALKP and hypoalbuminemia are risk factors for poor neurosurgical outcomes
Patient & Prescribing Data
Neurosurgical patients with TBI, ICH, or aSAH without severe pre-existing liver disease
Early identification of patients with abnormal liver function markers may inform tailored therapeutic approaches and improve prognosis
Clinical Best Practices
Integrate liver function testing into routine evaluation of neurosurgical patients
Utilize machine learning tools to enhance prognostic accuracy beyond traditional clinical scoring
Consider the liver-brain axis in the pathophysiology and management of neurosurgical conditions
Exclude patients with pre-existing severe liver disease when applying prognostic models based on liver function markers
Validate predictive models externally in multicenter cohorts before widespread clinical implementation
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.